Advertisement

Andover organ transplant tech company TransMedics Inc. has closed on $5.9 million of a planned $22.5 million in a new equity round, federal documents show.

The nine investors in the new round were not named in the filing with the U.S. Securities and Exchange Commission, but previous backers of the company have included a raft of firms – 3i Group, Alta Partners, CB Health Ventures, Flagship Ventures, JP Morgan, Posco BioVentures, Sagamore Bioventures, Sherbrooke Capital, Tudor Investment Corp. and VantagePoint Venture Partners.

SOURCE

Advertisement
Advertisement